What Will Our Relationship with Space Look Like in 2030

On the Space to Grow podcast, Astroscale’s Chris Blackerby and Charity Weeden bring their compelling experience and expertise to map out the technology, international policy, and scalability that will define the next generation of space exploration.

 

On this episode of Space To Grow, an Astroscale and Marketscale podcast, Astroscale’s Chris Blackerby and Charity Weeden dig into the role space plays in our lives, space exploration, and utilization. Many things impact space, including society, low-earth orbit, and lunar exploration.

Blackerby and Weeden talked to Dr. Timiebi Aganaba-Jeanty, a world-renown space lawyer and the founder of the Space Governance Lab at the School for the Future of Innovation in Society. She is also an assistant professor at the Future of Innovation in Society at Arizona State University and Sandra Day O Connor College of Law at Arizona State University.

“All of us have a role in the future we want, and believe it’s in our control, and we have the ability to control the future.” -Dr. Timiebi Aganaba-Jeanty

Aganaba-Jeanty has played a role in many things in space when it comes to governance and space. At ASU, where she holds dual roles, she founded the Space Governance Lab. She has a vision for herself and the future of space, which drives the meaning in her work. On the website at the Future of Innovation in Society, it says, “The Future is for Everyone,” and she believes that all humans play a role in the future of space exploration.

“Everyone should be able to see themselves in the future and how they can impact the future,” Aganab-Jeanty said. “All of us have a role in the future we want, and believe it’s in our control, and we have the ability to control the future.”

The trio dug into what students learn at the Future Innovation center. Aganaba-Jeanty talked about what students can learn and the careers they can go into. Further, they spoke about the role space has in all of our lives, whether we realize it or not.

Listen to Previous Episodes Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More